Skip to content
healthcare.dev

Abiraterone

NDC 72789-213, Abiraterone acetate, tablet, from PD-Rx Pharmaceuticals, Inc..

Product NDC
72789-213
Status
Listed
Labeler
PD-Rx Pharmaceuticals, Inc.
Dosage form
TABLET
Route
ORAL
Product type
HUMAN PRESCRIPTION DRUG
Marketing category
ANDA
Application
ANDA208339
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/72789-213 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • ABIRATERONE ACETATE250 mg/1

Pharmacologic classes

Cytochrome P450 17A1 Inhibitor [EPC]; Cytochrome P450 17A1 Inhibitors [MoA]; Cytochrome P450 2C8 Inhibitors [MoA]; Cytochrome P450 2D6 Inhibitors [MoA]

Package NDCNDC-11Package
72789-213-9872789021398120 TABLET in 1 BOTTLE, PLASTIC (72789-213-98)

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

  • FDA label sections

    GET /v1/drugs/labels/413c645e-074d-4276-b39a-d83521077602

Use it

Look up 72789-213 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/72789-213 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 72789-213. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.